TransThera Sciences Schedules 26 August Board Meeting to Review 1H 2026 Results and Consider Interim Dividend

Bulletin Express17:27

TransThera Sciences (Nanjing), Inc. has notified shareholders that its board of directors will convene on 26 August 2026 in Hong Kong. The meeting’s agenda includes three primary items:

1. Review and approval of the unaudited consolidated interim results for the six months ended 30 June 2026. 2. Consideration of an interim dividend declaration and payment. 3. Discussion of other routine matters.

The announcement, released on 14 August 2026, was signed by Dr. Frank Wu, who serves as both Chairman and Chief Executive Officer. The current board comprises Executive Directors Dr. Frank Wu and Mr. Wu Di; Non-Executive Director Ms. Jia Zhongxin; and Independent Non-Executive Directors Ms. Chui Hoi Yam, Mr. Feng Weibo, and Mr. Li Shu Pai.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment